Variants in the ataxia telangiectasia mutated gene ATM can increase the risk of breast cancer, though the gene is not on the ACMG v3.2 list of recommendations for reporting secondary findings in clinical exome and genome sequencing [33]. The gene discussed is ATM; the disease is breast carcinoma.